Role of GPR40 in the regulation of insulin secretion
GPR40在胰岛素分泌调节中的作用
基本信息
- 批准号:6899458
- 负责人:
- 金额:$ 7.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:blood chemistrycell surface receptorsdietary lipiddisease /disorder onsetenzyme linked immunosorbent assaygene induction /repressionglucose metabolismglucose tolerance testhomeostasisinsulininsulin sensitivity /resistancelaboratory mouselong chain fatty acidmetabolism disordernoninsulin dependent diabetes mellituspancreatic islet functionpathologic processpolymerase chain reactionreceptor bindingreceptor expressiontransfection /expression vector
项目摘要
DESCRIPTION (provided by applicant): Fatty acids acutely stimulate insulin secretion, but chronically impair pancreatic beta-cell function, a phenomenon likely to play a role in the pathogenesis of type 2 diabetes mellitus. Recently, a G-protein-coupled receptor specifically expressed on the surface of beta cells has been proposed as a long-chain fatty acid receptor. This challenges the current dogma that the effects of fatty acids on insulin secretion are mediated by their transmembrane transport and intracellular metabolism. The overall objective of the work described in this proposal is to define the role of the G-protein coupled receptor GPR40 in pancreatic beta-cell function. We have obtained preliminary data showing that gpr40 -/- mice develop glucose intolerance, and that islets isolated from these mice have defective fatty-acid potentiation of insulin secretion. Based on these preliminary findings, our hypothesis is that GPR40 plays an essential role in the regulation of insulin secretion by long-chain fatty acids. Specific aim 1 is to assess whether targeted deletion of gpr40 affects glucose homeostasis and insulin secretion in mice and precipitates the onset of diabetes upon high-fat feeding. We hypothesize that the lack of GPR40 will impair glucose homeostasis in vivo. Our preliminary findings support this hypothesis, but need to be further substantiated by measuring insulin secretion in response to various secretagogues as well as insulin sensitivity in vivo at different ages. We further hypothesize that the absence of GPR40 will precipitate the onset of diabetes in the context of high-fat diet-induced insulin resistance. Specific aim 2 is to determine whether loss of function of GPR40 impairs fuel metabolism and insulin secretion in isolated mouse islets. We hypothesize that islets isolated from gpr40 KO mice will have defective insulin secretion in response to FA. Our preliminary data showing impairment of FA-induced insulin release support this hypothesis, but need to be further substantiated by measuring insulin secretion in response to a variety of nutrient and non-nutrient stimuli and performing a comprehensive assessment of glucose and FA metabolism in islets from gpr40 -/- mice. As an alternative approach, we will knock down GPR40 expression in isolated adult mouse islets by RNA silencing using adenoviral technology.
描述(由申请人提供):脂肪酸急性刺激胰岛素的分泌,但长期损害胰腺β细胞功能,这种现象可能在2型糖尿病的发病机理中发挥作用。最近,已经提出了一种在β细胞表面表达的G蛋白偶联受体,已被提出为长链脂肪酸受体。这挑战了当前的教条,即脂肪酸对胰岛素分泌的作用是由它们的跨膜转运和细胞内代谢介导的。该提案中描述的工作的总体目的是定义G蛋白偶联受体GPR40在胰腺β细胞功能中的作用。我们已经获得了初步数据,表明GPR40 - / - 小鼠会出现葡萄糖不耐症,并且从这些小鼠中分离出的胰岛具有胰岛素分泌的脂肪酸性增强。基于这些初步发现,我们的假设是GPR40在长链脂肪酸对胰岛素分泌的调节中起着至关重要的作用。具体目标1是评估GPR40的靶向缺失是否会影响小鼠的葡萄糖稳态和胰岛素分泌,并在高脂喂养时沉淀糖尿病的发作。我们假设缺乏GPR40会损害体内葡萄糖稳态。我们的初步发现支持了这一假设,但需要通过测量胰岛素分泌来响应各种促分泌物以及在不同年龄的体内胰岛素敏感性来进一步证实。我们进一步假设,在高脂饮食诱导的胰岛素抵抗的背景下,GPR40的不存在会导致糖尿病的发作。具体目标2是确定GPR40功能的丧失是否会损害孤立小鼠胰岛中燃料代谢和胰岛素分泌。我们假设从GPR40 KO小鼠中分离出来的胰岛将对FA响应有缺陷的胰岛素分泌。我们的初步数据显示了FA诱导的胰岛素释放损害支持了这一假设,但需要通过测量胰岛素分泌来进一步证实,以响应各种营养和非营养刺激,并对GPR40-/ - / - / - - - / - - - / - - / - - / - - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - / - /)进行全面评估。作为另一种方法,我们将使用腺病毒技术通过RNA沉默来击败孤立的成年小鼠胰岛中的GPR40表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENT POITOUT其他文献
VINCENT POITOUT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENT POITOUT', 18)}}的其他基金
Role of GPR40 in the regulation of insulin secretion
GPR40在胰岛素分泌调节中的作用
- 批准号:
7019973 - 财政年份:2005
- 资助金额:
$ 7.35万 - 项目类别:
Role of GPR40 in the regulation of insulin secretion
GPR40在胰岛素分泌调节中的作用
- 批准号:
7124152 - 财政年份:2005
- 资助金额:
$ 7.35万 - 项目类别:
HB-EGF as a central regulator of pancreatic beta-cell proliferation
HB-EGF 作为胰腺 β 细胞增殖的中心调节因子
- 批准号:
9381112 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Mechanisms of Fatty-Acid Inhibition of the Insulin Gene
脂肪酸抑制胰岛素基因的机制
- 批准号:
7655254 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Neutral lipid dysregulation of the pancreatic beta-cell
胰腺β细胞的中性脂质失调
- 批准号:
6635296 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Mechanisms of Fatty-Acid Inhibition of the Insulin Gene
脂肪酸抑制胰岛素基因的机制
- 批准号:
7417538 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Mechanisms of Fatty-Acid Inhibition of the Insulin Gene
脂肪酸抑制胰岛素基因的机制
- 批准号:
8296373 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Mechanisms of Fatty-Acid Inhibition of the Insulin Gene
脂肪酸抑制胰岛素基因的机制
- 批准号:
7821485 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Neutral lipid dysregulation of the pancreatic beta-cell
胰腺β细胞的中性脂质失调
- 批准号:
6752050 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
Mechanisms of Fatty-Acid Inhibition of the Insulin Gene
脂肪酸抑制胰岛素基因的机制
- 批准号:
7150404 - 财政年份:2001
- 资助金额:
$ 7.35万 - 项目类别:
相似国自然基金
胃肠道Goblet细胞来源的TFF3通过与肝细胞表面TLR4受体结合保护酒精性肝损伤的机制探究
- 批准号:82370601
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ACP5上调调节性T细胞表面受体Layilin在诱导肝细胞癌免疫耐受中的作用与机制研究
- 批准号:82303149
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向c-MET以及CD133的串联双靶点嵌合抗原受体—巨噬细胞(CAR-M)对胰腺癌的杀伤及化疗协同增效作用及机制研究
- 批准号:82373230
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
炎症激活成纤维细胞表面受体TREM-1进而诱导异常成骨分化及后纵韧带骨化的机制研究
- 批准号:82372452
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多价核酸调控细胞表面受体改变细胞表型转化
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Deciphering the lipid composition of primary cilia in human metabolic disease
破译人类代谢疾病中初级纤毛的脂质成分
- 批准号:
10696465 - 财政年份:2023
- 资助金额:
$ 7.35万 - 项目类别:
GPR120 regulation of intestinal IgA responses and gut IgA-coated bacteria
GPR120 对肠道 IgA 反应和肠道 IgA 包被细菌的调节
- 批准号:
10176396 - 财政年份:2020
- 资助金额:
$ 7.35万 - 项目类别:
Regulation of Skeletal Development and Mechanosensitivity by the α2δ1 Auxiliary Voltage Sensitive Calcium Channel Subunit
α2β1 辅助电压敏感钙通道亚基对骨骼发育和机械敏感性的调节
- 批准号:
9920590 - 财政年份:2019
- 资助金额:
$ 7.35万 - 项目类别:
Regulation of Skeletal Development and Mechanosensitivity by the α2δ1 Auxiliary Voltage Sensitive Calcium Channel Subunit
α2β1 辅助电压敏感钙通道亚基对骨骼发育和机械敏感性的调节
- 批准号:
10188432 - 财政年份:2019
- 资助金额:
$ 7.35万 - 项目类别:
Regulation of Skeletal Development and Mechanosensitivity by the α2δ1 Auxiliary Voltage Sensitive Calcium Channel Subunit
α2β1 辅助电压敏感钙通道亚基对骨骼发育和机械敏感性的调节
- 批准号:
10402558 - 财政年份:2019
- 资助金额:
$ 7.35万 - 项目类别: